Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 124.65 -0.66 (0.53%)
Previous Close $125.31    52 Week High $118.49 
Open $125.00    52 Week Low $55.00 
Day High $127.41    P/E N/A 
Day Low $124.19    EPS $-0.56 
Volume 1,270,532       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1164.89 +11.96 (1.04%)
Previous Close $1152.93    52 Week High $88.16 
Open $1144.49    52 Week Low $67.88 
Day High $1170.90    P/E 269.65 
Day Low $1134.41    EPS $4.32 
Volume 2,479,448